Welcome to the Trial Talks podcast – a thought-provoking series surrounding clinical trial research. We’ll be exploring current and future trends of the ever-changing clinical trial landscape as we discuss a variety of topics including virtual trials, patient centricity, novel and unique research, pandemic impact, and more. Join us and our expert guests on a journey through the evolution of clinical trials.
All content for Trial Talks is the property of Medrio and is served directly from their servers
with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
Welcome to the Trial Talks podcast – a thought-provoking series surrounding clinical trial research. We’ll be exploring current and future trends of the ever-changing clinical trial landscape as we discuss a variety of topics including virtual trials, patient centricity, novel and unique research, pandemic impact, and more. Join us and our expert guests on a journey through the evolution of clinical trials.
It’s no secret that the United States has documented disparities in morbidity and mortality rates among racial/ethnic minority groups and those of lower socioeconomic status. More recently we’ve seen a disproportionate amount of African Americans affected by COVID-19, but they have been underrepresented in clinical research. In this podcast we are joined by Kimberly Richardson, Patient Advocate and Cancer Survivor, to discuss how we can work towards achieving health equity in the United States, what steps can be taken today, and the impact this would have on clinical research and underserved communities.
Trial Talks
Welcome to the Trial Talks podcast – a thought-provoking series surrounding clinical trial research. We’ll be exploring current and future trends of the ever-changing clinical trial landscape as we discuss a variety of topics including virtual trials, patient centricity, novel and unique research, pandemic impact, and more. Join us and our expert guests on a journey through the evolution of clinical trials.